Christopher Hui: The Hong Kong Stock Exchange has taken into account the needs of different investors when implementing the optimized mechanism for IPO pricing and allocation.

Xu Zhengyu mentioned that the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange will continue to closely review the quality of sponsor work and listing applications, and take appropriate regulatory actions when necessary to uphold Hong Kong's reputation as a leading international fundraising hub.

Zhitong FinanceMay 13 13:51

At a Glance: March's Hottest IPOs - Shangmi Technology Approved! Four New Stocks, Including ZhaoWei Electromechanical and EastControl, Undergoing Enthusiastic Subscription.

Hello, fellow investors! The New Stock Observer is here to provide updates on the popular HK IPOs in March and throughout 2026. Fellow investors, check it out now!

Futu NewsFeb 28 09:55

Edding Genor Renames Group and Changes Hong Kong Stock Short Name

TipRanksFeb 3 19:08

At a Glance: February's Hottest IPOs - Dongpeng Beverage and Guoen Technology Are Set to Go Public! Five New Stocks Including Montage Technology and Aixing Yuanzhi Are Under Active Subscription.

Hello, fellow investors! The NiuNiu New Shares team is pleased to present the popular IPOs in HK for February and 2026. Fellow investors, feel free to check them out~

Futu NewsJan 30 14:17

At a Glance: January's Hottest IPOs: First of the New Year! Biren Technology listed on the Hong Kong Stock Exchange on January 2nd, with 10 new stocks including Zhipu, MINIMAX, and TianShuZhiXin in active subscription.

Hello, fellow investors! The Futu IPO Assistant is here to provide you with the most popular IPOs in HK for January and 2026. Fellow investors, come and check them out!

Futu NewsDec 31, 2025 15:57

The M&A-driven Evolution of Edding Pharma and the 'Mutual Synergy' with JHBP (CY) Holdings Limited (06998)

Yiteng Pharmaceuticals completed its share exchange merger with Jiahor Bio through a reverse takeover and subsequent listing, marking the official launch of a 'reverse' Biopharma model.

Zhitong FinanceDec 31, 2025 12:34